Clinical Trial Update: A Study of AZD0120 in Autoimmune Diseases [Phase 1]

View source ↗

Summary

AZD0120 from AstraZeneca is in Phase 1 testing for autoimmune diseases, including systemic sclerosis, idiopathic inflammatory myopathies, and rheumatoid arthrit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Inflammatory Myopathies
• Rheumatoid Arthritis
• Systemic Sclerosis

Drugs mentioned

• AZD0120

Snippet

Sponsor: AstraZeneca | Conditions: Systemic Sclerosis, Idiopathic Inflammatory Myopathies | Phase 1 | Status: RECRUITING